200 related articles for article (PubMed ID: 9762777)
1. Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation.
ten Hacken NH; Timens W; Smith M; Drok G; Kraan J; Postma DS
Eur Respir J; 1998 Sep; 12(3):546-50. PubMed ID: 9762777
[TBL] [Abstract][Full Text] [Related]
2. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma.
ten Hacken NH; van der Vaart H; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1998 Sep; 158(3):902-7. PubMed ID: 9731024
[TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion molecules in nocturnal asthma: a possible role for VCAM-1 in ongoing airway wall inflammation.
ten Hacken NH; Postma DS; Bosma F; Drok G; Rutgers B; Kraan J; Timens W
Clin Exp Allergy; 1998 Dec; 28(12):1518-25. PubMed ID: 10024223
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation.
ten Hacken NH; Oosterhoff Y; Kauffman HF; Guevarra L; Satoh T; Tollerud DJ; Postma DS
Eur Respir J; 1998 Feb; 11(2):312-6. PubMed ID: 9551730
[TBL] [Abstract][Full Text] [Related]
5. Role of inflammation in nocturnal asthma.
Mackay TW; Wallace WA; Howie SE; Brown PH; Greening AP; Church MK; Douglas NJ
Thorax; 1994 Mar; 49(3):257-62. PubMed ID: 8202883
[TBL] [Abstract][Full Text] [Related]
6. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma.
Hakala K; Stenius-Aarniala B; Sovijärvi A
Chest; 2000 Nov; 118(5):1315-21. PubMed ID: 11083680
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma.
Oosterhoff Y; Hoogsteden HC; Rutgers B; Kauffman HF; Postma DS
Am J Respir Crit Care Med; 1995 Jan; 151(1):75-81. PubMed ID: 7812576
[TBL] [Abstract][Full Text] [Related]
8. Influence of natural antigenic exposure on expiratory flows, methacholine responsiveness, and airway inflammation in mild allergic asthma.
Boulet LP; Turcotte H; Boutet M; Montminy L; Laviolette M
J Allergy Clin Immunol; 1993 Apr; 91(4):883-93. PubMed ID: 8473677
[TBL] [Abstract][Full Text] [Related]
9. Inflammation in nocturnal asthma?
Postma DS; Oosterhoff Y; van Aalderen WM; Kauffman HF; Wempe JB; Koëter GH
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 2):S83-6. PubMed ID: 7952600
[TBL] [Abstract][Full Text] [Related]
10. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
[TBL] [Abstract][Full Text] [Related]
11. Airway inflammation in mild intermittent and in persistent asthma.
Vignola AM; Chanez P; Campbell AM; Souques F; Lebel B; Enander I; Bousquet J
Am J Respir Crit Care Med; 1998 Feb; 157(2):403-9. PubMed ID: 9476850
[TBL] [Abstract][Full Text] [Related]
12. Increased vascular expression of iNOS at day but not at night in asthmatic subjects with increased nocturnal airway obstruction.
ten Hacken NH; Postma DS; Drok G; Smith M; Kraan J; Timens W
Eur Respir J; 2000 Sep; 16(3):445-51. PubMed ID: 11028658
[TBL] [Abstract][Full Text] [Related]
13. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma.
Jarjour NN; Busse WW
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1474-7. PubMed ID: 7582279
[TBL] [Abstract][Full Text] [Related]
14. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
Weersink EJ; van Zomeren EH; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1144-50. PubMed ID: 9351614
[TBL] [Abstract][Full Text] [Related]
15. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects.
Oosterhoff Y; Koëter GH; De Monchy JG; Postma DS
Am Rev Respir Dis; 1993 Mar; 147(3):512-7. PubMed ID: 8442580
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.
Djukanović R; Wilson JW; Britten KM; Wilson SJ; Walls AF; Roche WR; Howarth PH; Holgate ST
Am Rev Respir Dis; 1990 Oct; 142(4):863-71. PubMed ID: 2221594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects.
Troyanov S; Ghezzo H; Cartier A; Malo JL
Thorax; 1994 Aug; 49(8):775-80. PubMed ID: 8091322
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids.
Sont JK; Han J; van Krieken JM; Evertse CE; Hooijer R; Willems LN; Sterk PJ
Thorax; 1996 May; 51(5):496-502. PubMed ID: 8711677
[TBL] [Abstract][Full Text] [Related]
19. Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma.
Hoshino M; Nakamura Y; Shin Z; Fukushima Y
Allergy; 1997 Aug; 52(8):814-20. PubMed ID: 9284980
[TBL] [Abstract][Full Text] [Related]
20. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
Brand PL; Duiverman EJ; Waalkens HJ; van Essen-Zandvliet EE; Kerrebijn KF
Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
